ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

174
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
•03 Aug 2020 14:57

Impact of SK Biopharm Lock-Up Expirations

In this insight, we provide an analysis of the upcoming lock-up expirations of SK Biopharmaceuticals (326030 KS), which are likely to put continued...

Logo
466 Views
Share
•12 Jul 2020 07:57

Last Week In Event SPACE: FamilyMart, Sina, Line Corp, Metlifecare, Accordia Golf, Jingjeng, O-Net

Last Week in Event SPACE ... Interestingly, the impact of FamilyMart Co Ltd (8028 JP)'s shareholder dynamic on price may not be what "smart"...

Logo
693 Views
Share
•07 Jul 2020 10:33

SK Biopharm - Clear Signs of Overshooting

In this insight, we discuss the clear signs of overshooting at SK Biopharmaceuticals (326030 KS)'s share price, which has now catapulted as the...

Logo
584 Views
Share
bullish•Netmarble
•06 Jul 2020 11:32

Netmarble Corp (SoTP Valuation Analysis) - Impact of Big Hit Entertainment

Our SoTP valuation of Netmarble Corp suggests a NAV of 11.7 trillion won or 135,828 won per share, representing a 16.1% higher upside versus...

Logo
516 Views
Share
•02 Jul 2020 11:54

SK Biopharmaceuticals: KOSPI 200 Inclusion Event

SK Biopharm is currently hitting the daily ceiling at ₩127,000.It is a whopping 160% increase from the IPO price of ₩49,000. Well, the opening...

Logo
685 Views
Share
x